Literature DB >> 24567433

Recent clinical advances in lung cancer management.

David H Johnson1, Joan H Schiller, Paul A Bunn.   

Abstract

Progress in lung cancer therapy has been slow but steady and has accelerated due to improvements in scientific basis for the disease and to technologic advances in diagnosis and therapy. The elusive goal of reduced mortality rates can be achieved in the next 50 years through continued interdisciplinary research efforts.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24567433     DOI： 10.1200/JCO.2013.53.1228

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


  88 in total

1.  Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer.

Authors:  Linda Kachuri; Jens Helby; Stig Egil Bojesen; David C Christiani; Li Su; Xifeng Wu; Adonina Tardón; Guillermo Fernández-Tardón; John K Field; Michael P Davies; Chu Chen; Gary E Goodman; Frances A Shepherd; Natasha B Leighl; Ming S Tsao; Yonathan Brhane; M Catherine Brown; Kevin Boyd; Daniel Shepshelovich; Lei Sun; Christopher I Amos; Geoffrey Liu; Rayjean J Hung
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-07       Impact factor: 4.254

2.  Smoking Among Chinese Livery Drivers.

Authors:  Jennifer C Leng; Lei Lei; Shu Fang Lei; Zhiying Zhu; Nancy Mo; Brian Sou; Imran Mujawar; Francesca Gany
Journal:  J Immigr Minor Health       Date:  2019-04

3.  JMJD2 promotes acquired cisplatin resistance in non-small cell lung carcinoma cells.

Authors:  Lei Duan; Ricardo E Perez; Paul D Chastain; Mathew T Mathew; Divya Rani Bijukumar; Carl G Maki
Journal:  Oncogene       Date:  2019-04-09       Impact factor: 9.867

4.  Comprehensive metastatic lung cancer care must include palliative care.

Authors:  A M Rosenblum; M Chasen
Journal:  Curr Oncol       Date:  2018-06-28       Impact factor: 3.677

5.  Targeting of Lung Cancer Stem Cell Self-Renewal Pathway by a Small Molecule Verrucarin J.

Authors:  Karen Udoh; Seema Parte; Kelsey Carter; Aaron Mack; Sham S Kakar
Journal:  Stem Cell Rev Rep       Date:  2019-08       Impact factor: 5.739

6.  The action and mechanism of myrislignan on A549 cells in vitro and in vivo.

Authors:  XinGang Lu; Liu Yang; JingXian Chen; JiAn Zhou; XiaoDan Tang; YingGang Zhu; HongFu Qiu; Jie Shen
Journal:  J Nat Med       Date:  2016-08-04       Impact factor: 2.343

7.  The evolution of tumor classification: a role for genomics?

Authors:  Paul A Bunn; Wilbur Franklin; Robert C Doebele
Journal:  Cancer Cell       Date:  2013-12-09       Impact factor: 31.743

8.  A novel function of anaphase promoting complex subunit 10 in tumor progression in non-small cell lung cancer.

Authors:  Yanan Wang; Tianyu Han; Mingxi Gan; Meng Guo; Caifeng Xie; Jiangbo Jin; Song Zhang; Pengcheng Wang; Jiaqing Cao; Jian-Bin Wang
Journal:  Cell Cycle       Date:  2019-04-25       Impact factor: 4.534

9.  Co-delivery of paclitaxel and cisplatin with biocompatible PLGA-PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models.

Authors:  Jing Tian; Yuanzeng Min; Zachary Rodgers; Kin Man Au; C Tilden Hagan; Maofan Zhang; Kyle Roche; Feifei Yang; Kyle Wagner; Andrew Z Wang
Journal:  J Mater Chem B       Date:  2017-07-05       Impact factor: 6.331

10.  PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer.

Authors:  Ankita Jhuraney; Nicholas T Woods; Gabriela Wright; Lily Rix; Fumi Kinose; Jodi L Kroeger; Elizabeth Remily-Wood; W Douglas Cress; John M Koomen; Stephen G Brantley; Jhanelle E Gray; Eric B Haura; Uwe Rix; Alvaro N Monteiro
Journal:  Mol Cancer Ther       Date:  2016-05-11       Impact factor: 6.261
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.